Project Grant R43DK139844
Award Date
9/2/24
Completion Date
8/31/25
Dollars Obligated
$1.1M
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $425,176 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to Eden Medical, Inc. to develop the "Smart Foot Mat" (SFM). The SFM is an in-home appliance designed to help prevent diabetic foot complications by allowing diabetic patients to monitor their foot oximetry and temperature on a daily basis. The grant funding will support the development of this novel...
The federal Project Grant award R43DK138596, totaling $712,628, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award is being used by Barron Associates, Inc., a small business R&D company, to develop the SoleSaver System - a sensor-enabled, foot-worn garment that can continuously monitor multiple aspects of foot health to enhance prevention and...
This $555,034 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund the "Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-FOOT-NAV)" randomized controlled trial. The primary objective is to assess the effectiveness of a comprehensive patient navigator program to improve healing rates for diabetic foot...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Lynntech, Inc. a $687,416 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award will fund the development of a cutaneous gel that can controllably deliver a small molecule therapeutic to effectively treat diabetic foot ulcers (DFUs). The project aims to: 1) prepare, characterize, and select a preferred gel formulation for controlled therapeutic...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is funding the development and clinical evaluation of a novel medical device for improving diabetic wound healing. The $268,377 award aims to enhance a high-frequency, low-amplitude vibration (HFLAV) driver device and conduct a small clinical trial to evaluate its safety and efficacy in treating...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $284,517 Project Grant (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) to Electronic Biosciences, Inc. to develop a point-of-care diagnostic assay for detecting autoantibodies associated with type 1 diabetes (T1D). This project aims to leverage nanopore technology to create a rapid, cost-effective test for screening populations, especially children, for T1D biomarkers that appear...
This $929,940 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA Program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research supports the development of a novel dual agonist biologic drug candidate to safely treat type I and type II diabetics experiencing impaired awareness of hypoglycemia (IAH). The project aims to pursue manufacturing, formulation, efficacy validation, and safety studies on 3 lead candidates over a...
Vivonics Inc., a medical technology company based in Massachusetts, received a $331,455 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) to develop a near-infrared layered imaging system called NIR-LITH. This system aims to provide objective, three-dimensional hemodynamic mapping of diabetic foot ulcers and surrounding tissue with 1 mm depth resolution, improving clinicians' ability to assess wound healing potential and make more accurate...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $500,928 to Pupil Bio, Inc. to develop an early detection test for Type 1 Diabetes (T1D) via next-generation sequencing (NGS) analysis of B cell-specific methylation patterns in cell-free DNA. The key products and services to be delivered include: Validating thousands of candidate...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $469,682 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to research a novel approach for diagnosing, monitoring, and treating bacterial infections in diabetic wounds. The key products and services delivered under this award include: 1)...